Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which therapy works best for teens with eating disorders? new study aims to find out

NCT ID NCT06256380

Symptom relief Sponsor: Oslo University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two types of talk therapy for teenagers with eating disorders: enhanced cognitive-behavior therapy and family-based treatment. About 200 adolescents will be randomly assigned to one of the two therapies. The goal is to see if cognitive-behavior therapy works as well as family-based treatment in reducing eating disorder symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
psychotherapy (cognitive-behavior therapy or family-based treatment)
What this could lead to
If successful, this could show that enhanced cognitive-behavior therapy is as effective as family-based treatment, giving families more options for care.
What could go wrong
This is a behavioral study with no drug; results depend on patient and family engagement. The design was modified due to recruitment challenges, which may affect reliability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Dec 2033

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosed eating disorder 2. Medically stable for outpatient treatment. 3. Living with at least one of their parents 4. At least one of their parents could be actively involved in the treatment 5. Sufficient knowledge in reading, understanding and speaking Norwegian Exclusion Criteria: 1. Avoidant restrictive food intake disorders 2. A co-morbid medical condition or disorder known to influence eating or weight, or influence the possibilities to take part in treatment 3. Psychotic disorders 4. Acute suicidality 5. Substance abuse and/or substance dependence 6. Serious traumatic events in the family making treatment following FBT or CBT-E manual not recommended 7. Unstable psychotropic medication last 6 weeks

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Feeding and eating disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

eating disorder Feeding and Eating Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Feeding and eating disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Haukeland University Hospital

    RECRUITING

    Bergen, 5009, Norway

  • Oslo University Hospital

    RECRUITING

    Oslo, 0424, Norway

  • St. Olav Hospital

    RECRUITING

    Trondheim, 7030, Norway

  • University Hospital of North Norway

    RECRUITING

    Tromsø, 9019, Norway

  • Vestre Viken Health Trust

    RECRUITING

    Drammen, 30004, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.